St. Jude Medical, Inc. (STJ) Tops Q4 EPS by 2c; Guides Q1, FY12 EPS Below Views

January 25, 2012 7:35 AM EST Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) reported Q4 EPS of $0.86, $0.02 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.4 billion.

St. Jude Medical, Inc. sees FY2012 EPS of $3.43-$3.48, versus the consensus of $3.51.

St. Jude Medical, Inc. sees Q1 2012 EPS of $0.82-$0.84, versus the consensus of $0.85.

For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment